Fatigue News and Research

RSS

New mathematical model predicts the spread of COVID-19

Scientists at the U.S. Department of Energy's (DOE) Brookhaven National Laboratory and the University of Illinois Urbana-Champaign (UIUC) have developed a new mathematical model for predicting how epidemics such as COVID-19 spread.

22 Apr 2021

People with multiple sclerosis experience subtle language impairments, study shows

Kessler Foundation researchers showed that people with multiple sclerosis (MS) experience subtle language impairments that standard neuropsychological tests may incorrectly attribute to impaired executive functions.

22 Apr 2021

Personal and work-related factors can increase risk for neck pain

With roughly 80% of jobs being sedentary, often requiring several hours of sitting stooped in front of a computer screen, neck pain is a growing occupational hazard. Smartphones and other devices have also caused people to bend their necks for prolonged periods. But is bad posture solely to blame?

20 Apr 2021

Light therapy offers a safe, cost-effective alternative for treatment of neurodegenerative diseases

A lot about the human brain and its intricacies continue to remain a mystery. With the advancement of neurobiology, the pathogenesis of several neurodegenerative diseases (ND) has been uncovered to a certain extent along with molecular targets around which current therapies revolve.

19 Apr 2021

Researchers investigate whether muscle pump action systematically changes with age

Chronic lower-limb edema (CLE) -- the permanent accumulation of fluid in the leg -- often occurs in elderly people.

19 Apr 2021

FDA approves immunotherapy for first-line treatment of advanced gastric cancer

Today, the U.S. Food and Drug Administration approved Opdivo (nivolumab), in combination with certain types of chemotherapy, for the initial treatment of patients with advanced or metastatic gastric cancer, gastroesophageal junction cancer and esophageal adenocarcinoma.

16 Apr 2021

Mysterious ailment, mysterious relief: Vaccines help some Covid long haulers

An estimated 10% to 30% of people who get Covid-19 suffer from lingering symptoms of the disease, or what’s known as “long Covid.”

16 Apr 2021

Researchers identify risk factors for SARS-CoV-2 reinfection

A team of scientists from the Capital Medical University and Peking University, China, has recently explored the factors responsible for the reactivation of SARS-CoV-2 infection among individuals who have recently recovered from COVID-19. The findings reveal that individuals with lower lymphocyte count or with two or fewer symptoms during the first COVID-19 episode are at higher risk of recurrent infection.

16 Apr 2021

Recovered COVID-19 patients may need only a single vaccine dose, suggests study

People who have recovered from COVID-19 had a robust antibody response after the first mRNA vaccine dose, but little immune benefit after the second dose, according to new research from the Penn Institute of Immunology. The findings, published today in Science Immunology, suggest only a single vaccine dose may be needed to produce a sufficient antibody response.

16 Apr 2021

Feline model of SARS-CoV-2 infection imitates COVID-19 in humans

Researchers in the United States have validated a feline model of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that closely imitates coronavirus disease 2019 (COVID-19) in humans.

15 Apr 2021

More than half of COVID-19 patients report persistent symptoms 12-months after infection

In a new study, appearing on the pre-print server medRxiv*, researchers at the University of Trieste and Istituto Auxologico Italiano IRCCS in Italy report that more than half of patients with previous mild-to-moderate symptomatic COVID-19 complained of the persistence of at least one symptom 12-months after the onset of the illness.

15 Apr 2021

Does natural infection with SARS-CoV-2 offer more protection than a vaccine against new variants?

A new study demonstrates that vaccines may be less effective at countering the newer SARS-CoV-2 variants compared to natural infection.

9 Apr 2021

New digital platform to aid young Aussies living with incurable movement disorder

More than 20,000 young Aussies (under 50 years of age) living with an incurable movement disorder are set to benefit from the launch of an Australian-first digital support platform today (Thursday, April 8, 2021), ahead of World Parkinson’s Day (Sunday, April 11, 2021).

9 Apr 2021

Study: 1 in 10 people still has moderate to severe symptoms after mild COVID-19

Eight months after mild COVID-19, one in ten people still has at least one moderate to severe symptom that is perceived as having a negative impact on their work, social or home life. The most common long-term symptoms are a loss of smell and taste and fatigue.

8 Apr 2021

Fatigue News and Research

New mathematical model predicts the spread of COVID-19

People with multiple sclerosis experience subtle language impairments, study shows

Personal and work-related factors can increase risk for neck pain

Light therapy offers a safe, cost-effective alternative for treatment of neurodegenerative diseases

Researchers investigate whether muscle pump action systematically changes with age

FDA approves immunotherapy for first-line treatment of advanced gastric cancer

Mysterious ailment, mysterious relief: Vaccines help some Covid long haulers

Researchers identify risk factors for SARS-CoV-2 reinfection

Recovered COVID-19 patients may need only a single vaccine dose, suggests study

Feline model of SARS-CoV-2 infection imitates COVID-19 in humans

More than half of COVID-19 patients report persistent symptoms 12-months after infection

Does natural infection with SARS-CoV-2 offer more protection than a vaccine against new variants?

New digital platform to aid young Aussies living with incurable movement disorder

Study: 1 in 10 people still has moderate to severe symptoms after mild COVID-19

New test for Lyme disease can reliably distinguish between early- and late-stage patients

Study shows stronger link between Down syndrome and acute myeloid leukemia

Temple, Case Western scientists receive $3 million NIH grant to study pathway behind heart failure

Signal detection theory can be used to better understand cognitive fatigue

Researchers identify potential trigger of Crohn's disease

New Phase 1 clinical trial of investigational vaccine against B.1.351 SARS-CoV-2 variant begins

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News